Attached files

file filename
8-K - FORM 8-K - CRANE CO /DE/d338586d8k.htm
EX-99.1 - PRESS RELEASE - CRANE CO /DE/d338586dex991.htm

Exhibit 99.2

CRANE CO.

Income Statement Data

(in thousands, except per share data)

 

     Three Months Ended  
     March 31,  
     2011     2011  

Net Sales:

    

Aerospace & Electronics

   $ 175,168      $ 161,936   

Engineered Materials

     58,159        61,832   

Merchandising Systems

     87,675        94,878   

Fluid Handling

     301,886        264,142   

Controls

     34,991        28,232   
  

 

 

   

 

 

 

Total Net Sales

   $ 657,879      $ 611,020   
  

 

 

   

 

 

 

Operating Profit (Loss):

    

Aerospace & Electronics

   $ 38,069      $ 34,042   

Engineered Materials

     8,409        10,143   

Merchandising Systems

     4,713        4,673   

Fluid Handling

     39,640        35,453   

Controls

     4,701        3,111   

Corporate

     (15,972     (14,562
  

 

 

   

 

 

 

Total Operating Profit

     79,560        72,860   

Interest Income

     395        290   

Interest Expense

     (6,711     (6,622

Miscellaneous- Net

     (347     3,625
  

 

 

   

 

 

 

Income Before Income Taxes

     72,897        70,153   

Provision for Income Taxes

     21,101        21,775   
  

 

 

   

 

 

 

Net income before allocations to noncontrolling interests

     51,796        48,378   

Less: Noncontrolling interest in subsidiaries’ gains (losses)

     134        (89
  

 

 

   

 

 

 

Net income attributable to common shareholders

   $ 51,662      $ 48,467   
  

 

 

   

 

 

 

Share Data:

    

Earnings per Diluted Share

   $ 0.88      $ 0.81   
  

 

 

   

 

 

 

Average Diluted Shares Outstanding

     58,880        59,552   

Average Basic Shares Outstanding

     57,889        58,330   

Supplemental Data:

    

Cost of Sales

   $ 437,471      $ 397,850   

Selling, General & Administrative

     140,848        140,310   

Depreciation and Amortization **

     14,674        15,774   

Stock-Based Compensation Expense

     4,007        3,503   

 

* Primarily related to the sale of a building and the divestiture of a small product line in the three months ended March 31, 2011.
** Amount included within cost of sales and selling, general & administrative costs.


CRANE CO.

Condensed Balance Sheets

(in thousands)

 

     March 31,
2012
     December 31,
2011
 

ASSETS

     

Current Assets

     

Cash and Cash Equivalents

   $ 195,860       $ 245,089   

Accounts Receivable, net

     404,418         349,250   

Current Insurance Receivable - Asbestos

     16,345         16,345   

Inventories, net

     368,495         360,689   

Other Current Assets

     64,092         60,859   
  

 

 

    

 

 

 

Total Current Assets

     1,049,210         1,032,232   

Property, Plant and Equipment, net

     284,289         284,146   

Long-Term Insurance Receivable - Asbestos

     204,929         208,952   

Other Assets

     485,268         497,377   

Goodwill

     826,717         820,824   
  

 

 

    

 

 

 

Total Assets

   $ 2,850,413       $ 2,843,531   
  

 

 

    

 

 

 

LIABILITIES AND EQUITY

     

Current Liabilities

     

Notes Payable and Current Maturities of Long-Term Debt

   $ 794       $ 1,112   

Accounts Payable

     184,319         194,158   

Current Asbestos Liability

     100,943         100,943   

Accrued Liabilities

     187,006         226,717   

Income Taxes

     14,745         10,165   
  

 

 

    

 

 

 

Total Current Liabilities

     487,807         533,095   

Long-Term Debt

     398,958         398,914   

Long-Term Deferred Tax Liability

     42,664         41,668   

Long-Term Asbestos Liability

     770,443         792,701   

Other Liabilities

     254,685         255,097   

Total Equity

     895,856         822,056   
  

 

 

    

 

 

 

Total Liabilities and Equity

   $ 2,850,413       $ 2,843,531   
  

 

 

    

 

 

 


CRANE CO.

Condensed Statements of Cash Flows

(in thousands)

 

     Three Months Ended  
     March 31,  
     2012     2011  

Operating Activities:

    

Net income attributable to common shareholders

   $ 51,662      $ 48,467   

Noncontrolling interest in subsidiaries’ gains (losses)

     134        (89
  

 

 

   

 

 

 

Net income before allocations to noncontrolling interests

     51,796        48,378   

Gain on divestiture

     —          (4,258

Depreciation and amortization

     14,674        15,774   

Stock-based compensation expense

     4,007        3,503   

Defined benefit plans and postretirement expense

     4,991        2,749   

Deferred income taxes

     8,544        6,893   

Cash used for operating working capital

     (103,503     (67,250

Defined benefit plans and postretirement contributions

     (1,183     (4,779

Environmental payments, net of reimbursements

     (2,579     (4,593

Other

     (1,319     142   
  

 

 

   

 

 

 

Subtotal

     (24,572     (3,441

Asbestos related payments, net of insurance recoveries

     (18,235     (12,725
  

 

 

   

 

 

 

Total used for operating activities

     (42,807     (16,166
  

 

 

   

 

 

 

Investing Activities:

    

Capital expenditures

     (7,165     (8,138

Proceeds from disposition of capital assets

     172        4,553   

Proceeds from divestiture

     —          1,000   
  

 

 

   

 

 

 

Total used for investing activities

     (6,993     (2,585
  

 

 

   

 

 

 

Financing Activities:

    

Dividends paid

     (15,090     (13,474

Reacquisition of shares on open market

     —          (29,999

Stock options exercised - net of shares reacquired

     8,426        12,552   

Excess tax benefit from stock-based compensation

     2,947        3,952   

Change in short-term debt

     (318     (76
  

 

 

   

 

 

 

Total used for financing activities

     (4,035     (27,045
  

 

 

   

 

 

 

Effect of exchange rate on cash and cash equivalents

     4,606        6,017   
  

 

 

   

 

 

 

Decrease in cash and cash equivalents

     (49,229     (39,779

Cash and cash equivalents at beginning of period

     245,089        272,941   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 195,860      $ 233,162   
  

 

 

   

 

 

 


CRANE CO.

Order Backlog

(in thousands)

 

     March 31,     December 31,     September 30,     June 30,      March 31,  
     2012     2011     2011     2011      2011  

Aerospace & Electronics

   $ 437,822      $ 410,794      $ 409,284      $ 431,799       $ 454,559   

Engineered Materials

     11,129        11,110        9,879        13,087         13,826   

Merchandising Systems

     30,033        15,212        20,929        26,898         25,008   

Fluid Handling

     337,538     313,715     328,757     323,045         305,255   

Controls

     29,770        27,120        32,145        30,323         24,015   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

Total Backlog

   $ 846,292      $ 777,951      $ 800,994      $ 825,152       $ 822,663   
  

 

 

   

 

 

   

 

 

   

 

 

    

 

 

 

 

* Includes Order Backlog of $7.5 million at March 31, 2012, $7.1 million at December 31, 2011 and $5.4 million at September 30, 2011 pertaining to the 2011 acquisition of WTA.


   CRANE CO.   
   Non-GAAP Financial Measures   
   (in thousands)   

 

     Three Months Ended  
     March 31,  
     2012     2011  
CASH FLOW ITEMS     

Cash Used for Operating Activities before Asbestos - Related Payments

   $ (24,572   $ (3,441

Asbestos Related Payments, Net of Insurance Recoveries

     (18,235     (12,725
  

 

 

   

 

 

 

Cash Used for Operating Activities

     (42,807     (16,166

Less: Capital Expenditures

     (7,165     (8,138
  

 

 

   

 

 

 

Free Cash Flow

   $ (49,972   $ (24,304
  

 

 

   

 

 

 

Certain non-GAAP measures have been provided to facilitate comparison with the prior year.

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (GAAP). However, management believes that non-GAAP financial measures which exclude certain non-recurring items present additional useful comparisons between current results and results in prior operating periods, providing investors with a clearer view of the underlying trends of the business. Management also uses these non-GAAP financial measures in making financial, operating, planning and compensation decisions and in evaluating the Company’s performance.

In addition, Free Cash Flow provides supplemental information to assist management and investors in analyzing the Company’s ability to generate liquidity from its operating activities. The measure of Free Cash Flow does not take into consideration certain other non-discretionary cash requirements such as, for example, mandatory principle payments on the Company’s long-term debt. Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.

Non-GAAP financial measures, which may be inconsistent with similarly captioned measures presented by other companies, should be viewed in the context of the definitions of the elements of such measures we provide and in addition to, and not as a substitute for, the Company’s reported results prepared in accordance with GAAP.